Home / Encyclopedia / Respiratory & Pulmonary
🫁 Category
Respiratory & Pulmonary.
Lung-targeted peptides in clinical and preclinical development for fibrosis, emphysema, inflammation and mucus regulation.
Respiratory & Pulmonary
LTI-03
LTI-03 is Rein Therapeutics' inhaled, first-in-class peptide derived from Caveolin-1, in a global Phase 2 trial for idiopathic pulmonary fibrosis.
Respiratory & Pulmonary
PR1P
PR1P is a 12-amino-acid, VEGF-stabilising research peptide studied preclinically for emphysema and acute lung injury.
Respiratory & Pulmonary
C6 Peptide
The C6 peptide blocks Hv1 proton channels in neutrophils, studied preclinically to suppress the lung inflammation seen in ARDS.
Respiratory & Pulmonary
SP9
SP9 (PEN-SP9) is a Stanford-developed stapled peptide that blocks rapid mucin secretion, studied for asthma, COPD and cystic fibrosis.